NBD AI Bulletin -- Yifan Pharmaceutical Co., Ltd (SZ 002019, close price: 21.53 yuan) announced on February 28 that the Company's controlling shareholder Cheng Xianfeng on February 26, 2021 released 33.8 million shares that were pledged to China Merchants Securities and the shares account for 6.81% of his holdings in the Company. On February 25, 2021, Cheng pledged 22.5 million shares, accounting for 4.53% of his holdings in the Company. As of the date of the announcement, Cheng Xianfeng has cumulatively pledged 58.27 million shares, representing 11.74% of his holdings in the Company.

The 2020 semiannual report shows that the main business of Yifan Pharmaceutical is medicine, pharmaceutical raw materials and intermediates, polymer materials, accounting for 59.59%, 35.41%, 5.01% of revenue, respectively.

Yifan Pharmaceutical's chairman and general manager is Cheng Xianfeng, male, 53 years old, Chinese national, master's degree.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.